These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30096639)

  • 1. Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study.
    Guterstam J; Jayaram-Lindström N; Berrebi J; Petrovic P; Ingvar M; Fransson P; Franck J
    Drug Alcohol Depend; 2018 Oct; 191():91-97. PubMed ID: 30096639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans.
    Courtney KE; Ghahremani DG; Ray LA
    Neuropsychopharmacology; 2016 Nov; 41(12):2872-2881. PubMed ID: 27312405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.
    Karl D; Bumb JM; Bach P; Dinter C; Koopmann A; Hermann D; Mann K; Kiefer F; Vollstädt-Klein S
    Psychopharmacology (Berl); 2021 Aug; 238(8):2179-2189. PubMed ID: 33846866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.
    Shi Z; Wang AL; Jagannathan K; Fairchild VP; O'Brien CP; Childress AR; Langleben DD
    J Psychiatry Neurosci; 2018 Jul; 43(4):254-261. PubMed ID: 29947607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
    Jayaram-Lindström N; Konstenius M; Eksborg S; Beck O; Hammarberg A; Franck J
    Neuropsychopharmacology; 2008 Jul; 33(8):1856-63. PubMed ID: 17957221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery.
    Savulich G; Riccelli R; Passamonti L; Correia M; Deakin JF; Elliott R; Flechais RS; Lingford-Hughes AR; McGonigle J; Murphy A; Nutt DJ; Orban C; Paterson LM; Reed LJ; Smith DG; Suckling J; Tait R; Taylor EM; Sahakian BJ; Robbins TW; Ersche KD
    Transl Psychiatry; 2017 Mar; 7(3):e1054. PubMed ID: 28267152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients.
    Langleben DD; Ruparel K; Elman I; Loughead JW; Busch EL; Cornish J; Lynch KG; Nuwayser ES; Childress AR; O'Brien CP
    Addict Biol; 2014 Mar; 19(2):262-71. PubMed ID: 22747521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.
    Kohno M; Dennis LE; McCready H; Schwartz DL; Hoffman WF; Korthuis PT
    Drug Alcohol Depend; 2018 Nov; 192():186-192. PubMed ID: 30266003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.
    Roche DJO; Worley MJ; Courtney KE; Bujarski S; London ED; Shoptaw S; Ray LA
    Psychopharmacology (Berl); 2017 Jul; 234(13):1997-2007. PubMed ID: 28357460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural substrates of cue reactivity and craving in gambling disorder.
    Limbrick-Oldfield EH; Mick I; Cocks RE; McGonigle J; Sharman SP; Goldstone AP; Stokes PR; Waldman A; Erritzoe D; Bowden-Jones H; Nutt D; Lingford-Hughes A; Clark L
    Transl Psychiatry; 2017 Jan; 7(1):e992. PubMed ID: 28045460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging.
    Mann K; Vollstädt-Klein S; Reinhard I; Leménager T; Fauth-Bühler M; Hermann D; Hoffmann S; Zimmermann US; Kiefer F; Heinz A; Smolka MN
    Alcohol Clin Exp Res; 2014 Nov; 38(11):2754-62. PubMed ID: 25421512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.
    Jayaram-Lindström N; Guterstam J; Häggkvist J; Ericson M; Malmlöf T; Schilström B; Halldin C; Cervenka S; Saijo T; Nordström AL; Franck J
    Transl Psychiatry; 2017 Apr; 7(4):e1104. PubMed ID: 28440810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone.
    Bach P; Weil G; Pompili E; Hoffmann S; Hermann D; Vollstädt-Klein S; Mann K; Perez-Ramirez U; Moratal D; Canals S; Dursun SM; Greenshaw AJ; Kirsch P; Kiefer F; Sommer WH
    Addict Biol; 2020 Jan; 25(1):e12717. PubMed ID: 30748046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials.
    Lam L; Anand S; Li X; Tse ML; Zhao JX; Chan EW
    Clin Toxicol (Phila); 2019 Apr; 57(4):225-233. PubMed ID: 30451013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses.
    Lim AC; Grodin EN; Green R; Venegas A; Meredith LR; Courtney KE; Moallem NR; Sayegh P; London ED; Ray LA
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):565-576. PubMed ID: 32343625
    [No Abstract]   [Full Text] [Related]  

  • 17. Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.
    Hyman SM; Fox H; Hong KI; Doebrick C; Sinha R
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):134-43. PubMed ID: 17469937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat.
    Häggkvist J; Björkholm C; Steensland P; Lindholm S; Franck J; Schilström B
    Addict Biol; 2011 Jan; 16(1):20-9. PubMed ID: 20192948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory.
    Tolliver BK; McRae-Clark AL; Saladin M; Price KL; Simpson AN; DeSantis SM; Baker NL; Brady KT
    Am J Drug Alcohol Abuse; 2010 Mar; 36(2):106-13. PubMed ID: 20337507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Craving correlates with mesolimbic responses to heroin-related cues in short-term abstinence from heroin: an event-related fMRI study.
    Li Q; Wang Y; Zhang Y; Li W; Yang W; Zhu J; Wu N; Chang H; Zheng Y; Qin W; Zhao L; Yuan K; Liu J; Wang W; Tian J
    Brain Res; 2012 Aug; 1469():63-72. PubMed ID: 22759909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.